Docket Room.
HR 10359·Federal·house

Priority for Pediatric Cures Act

In CommitteeFiled Sep 14, 2026
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12] (R)
Latest Action

Referred to the House Committee on Energy and Commerce.

Sep 14, 2026

Email me when HR 10359 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HR 10359. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill changes the Federal Food, Drug, and Cosmetic Act so the Secretary of Health and Human Services can keep giving priority review vouchers for medicines that treat rare diseases in children. It helps drug makers who develop these treatments by preserving a valuable incentive, and it aims to speed up access for patients who need them.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HR 10359

3 free questions a day, no account

Sponsors

  • Rep. Bilirakis, Gus M. [R-FL-12] (R) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HR 10359 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HR 10359 free

Or ask your AI assistant about HR 10359 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice